Therefore, targeting the Nrf2-ALDH2/PolG2 pathway can both alter mitochondrial respiration and inhibit mtDNA synthesis to disrupt mitochondrial homoeostasis and increase the sensitivity of AML cells to chemotherapy drugs. This evidence concerns the gene ALDH2 and acute myeloid leukemia.